← Open Payments lookup

ALEXANDER LARSON: Open Payments

NPI 1679168223 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$658 in 27 payments from 16 companies in 2025. Trend: 2023 $420 · 2024 $801 · 2025 $658

Food & beverage: $658
CompanyPaymentsAmount
Amgen Inc.4$199
AstraZeneca Pharmaceuticals LP3$78
GlaxoSmithKline, LLC.3$63
Dexcom, Inc.2$47
Novo Nordisk Inc2$40
ABBVIE INC.2$39
Lilly USA, LLC2$34
Takeda Pharmaceuticals U.S.A., Inc.1$22
Phathom Pharmaceuticals, Inc.1$19
PFIZER INC.1$19

Products named: FARXIGA, Dexcom G6 Transmitter, TRELEGY ELLIPTA, OTEZLA, REPATHA, TRINTELLIX, UBRELVY, Ozempic.

Industry payments across ID — which companies pay providers there.